Amount raised
€42M
€42,479,628
Native amount
46,000,000 USD
Stage
Series B
series b
Investors
7
Provenance & confidence
High confidenceAmount
46,000,000 USD
ECB-at-date → €42M · rate 1.0854 on 2024-05-23
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7Andera PartnersBritish Patient CapitalCanaanEarlybird Venture CapitalICG’s Life SciencesOxford Science EnterprisesPfizer Ventures
Date
May 2024
Round type
series b
Amount (EUR)
€42M
Other rounds
same companyRelated news
- Grey Wolf Therapeutics Closes $49M Series B Financingfinsmes.com · 2023-01
- eu-startups.com